Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 16538 | 23.2 |
09:34 ET | 600 | 23.24 |
09:36 ET | 2482 | 23.3 |
09:38 ET | 32218 | 23.38 |
09:39 ET | 9900 | 23.4 |
09:41 ET | 5754 | 23.34 |
09:43 ET | 9615 | 23.43 |
09:45 ET | 400 | 23.47 |
09:48 ET | 1907 | 23.435 |
09:50 ET | 518 | 23.44 |
09:52 ET | 200 | 23.42 |
09:54 ET | 700 | 23.44 |
09:56 ET | 1410 | 23.44 |
09:57 ET | 2000 | 23.43 |
09:59 ET | 300 | 23.43 |
10:01 ET | 47882 | 23.47 |
10:03 ET | 4000 | 23.5 |
10:06 ET | 2988 | 23.48 |
10:08 ET | 1700 | 23.48 |
10:10 ET | 1100 | 23.475 |
10:12 ET | 9223 | 23.52 |
10:14 ET | 6416 | 23.49 |
10:15 ET | 4700 | 23.48 |
10:17 ET | 5679 | 23.5 |
10:19 ET | 3400 | 23.51 |
10:21 ET | 600 | 23.545 |
10:24 ET | 3442 | 23.52 |
10:26 ET | 900 | 23.49 |
10:28 ET | 300 | 23.49 |
10:30 ET | 1200 | 23.49 |
10:32 ET | 1050 | 23.435 |
10:33 ET | 426 | 23.44 |
10:35 ET | 416 | 23.43 |
10:37 ET | 1400 | 23.45 |
10:39 ET | 62686 | 23.56 |
10:42 ET | 1739 | 23.52 |
10:44 ET | 3183 | 23.61 |
10:46 ET | 2495 | 23.61 |
10:48 ET | 3725 | 23.54 |
10:50 ET | 10444 | 23.57 |
10:51 ET | 850 | 23.57 |
10:53 ET | 2689 | 23.6 |
10:55 ET | 1000 | 23.61 |
10:57 ET | 1669 | 23.61 |
11:00 ET | 500 | 23.64 |
11:02 ET | 1100 | 23.64 |
11:04 ET | 2616 | 23.61 |
11:06 ET | 1493 | 23.61 |
11:08 ET | 100 | 23.6 |
11:09 ET | 140949 | 23.55 |
11:11 ET | 9802 | 23.46 |
11:13 ET | 3665 | 23.42 |
11:15 ET | 2652 | 23.37 |
11:18 ET | 1900 | 23.31 |
11:20 ET | 6377 | 23.32 |
11:22 ET | 625 | 23.32 |
11:24 ET | 2122 | 23.31 |
11:26 ET | 1200 | 23.32 |
11:27 ET | 4424 | 23.3 |
11:29 ET | 3400 | 23.28 |
11:31 ET | 4833 | 23.32 |
11:33 ET | 614 | 23.31 |
11:36 ET | 1350 | 23.31 |
11:38 ET | 3507 | 23.3 |
11:40 ET | 932 | 23.275 |
11:42 ET | 900 | 23.28 |
11:44 ET | 1382 | 23.31 |
11:45 ET | 4100 | 23.315 |
11:47 ET | 3948 | 23.29 |
11:49 ET | 17528 | 23.34 |
11:51 ET | 3787 | 23.325 |
11:54 ET | 8999 | 23.34 |
11:56 ET | 2438 | 23.35 |
11:58 ET | 200 | 23.36 |
12:00 ET | 2771 | 23.355 |
12:02 ET | 3298 | 23.3 |
12:03 ET | 600 | 23.3 |
12:05 ET | 400 | 23.29 |
12:07 ET | 2269 | 23.27 |
12:09 ET | 1100 | 23.24 |
12:12 ET | 1744 | 23.26 |
12:14 ET | 925 | 23.25 |
12:16 ET | 1433 | 23.28 |
12:18 ET | 48648 | 23.25 |
12:20 ET | 229291 | 23.32 |
12:21 ET | 41112 | 23.375 |
12:23 ET | 1762 | 23.36 |
12:25 ET | 16581 | 23.42 |
12:27 ET | 2913 | 23.48 |
12:30 ET | 2592 | 23.49 |
12:32 ET | 1980 | 23.47 |
12:34 ET | 700 | 23.455 |
12:36 ET | 850 | 23.46 |
12:38 ET | 1200 | 23.45 |
12:39 ET | 400 | 23.42 |
12:41 ET | 3618 | 23.4 |
12:43 ET | 5098 | 23.42 |
12:45 ET | 400 | 23.42 |
12:48 ET | 1550 | 23.44 |
12:50 ET | 800 | 23.44 |
12:52 ET | 100 | 23.44 |
12:54 ET | 695 | 23.44 |
12:56 ET | 200 | 23.44 |
12:57 ET | 1000 | 23.43 |
12:59 ET | 200 | 23.435 |
01:01 ET | 1368 | 23.45 |
01:03 ET | 300 | 23.455 |
01:06 ET | 3942 | 23.42 |
01:08 ET | 2700 | 23.415 |
01:10 ET | 2064 | 23.42 |
01:12 ET | 54334 | 23.44 |
01:14 ET | 7255 | 23.42 |
01:15 ET | 2675 | 23.42 |
01:17 ET | 1555 | 23.425 |
01:19 ET | 615 | 23.43 |
01:21 ET | 26073 | 23.43 |
01:24 ET | 9821 | 23.435 |
01:26 ET | 400 | 23.435 |
01:28 ET | 50478 | 23.39 |
01:30 ET | 16000 | 23.41 |
01:32 ET | 2600 | 23.42 |
01:33 ET | 8768 | 23.43 |
01:35 ET | 1500 | 23.445 |
01:37 ET | 500 | 23.445 |
01:39 ET | 6080 | 23.43 |
01:42 ET | 4300 | 23.42 |
01:44 ET | 5308 | 23.425 |
01:46 ET | 900 | 23.47 |
01:48 ET | 3282 | 23.485 |
01:50 ET | 3209 | 23.5 |
01:51 ET | 200 | 23.505 |
01:53 ET | 7498 | 23.465 |
01:55 ET | 700 | 23.475 |
01:57 ET | 479 | 23.475 |
02:00 ET | 4439 | 23.475 |
02:02 ET | 4844 | 23.45 |
02:04 ET | 2262 | 23.46 |
02:06 ET | 1500 | 23.47 |
02:08 ET | 816 | 23.485 |
02:09 ET | 3668 | 23.5 |
02:11 ET | 200 | 23.5 |
02:13 ET | 2018 | 23.505 |
02:15 ET | 2290 | 23.49 |
02:18 ET | 2500 | 23.5 |
02:20 ET | 1692 | 23.505 |
02:22 ET | 500 | 23.51 |
02:24 ET | 500 | 23.505 |
02:26 ET | 1200 | 23.51 |
02:27 ET | 2300 | 23.505 |
02:29 ET | 4217 | 23.52 |
02:31 ET | 2255 | 23.48 |
02:33 ET | 400 | 23.485 |
02:36 ET | 2100 | 23.48 |
02:38 ET | 400 | 23.475 |
02:40 ET | 600 | 23.475 |
02:42 ET | 2480 | 23.48 |
02:44 ET | 1100 | 23.48 |
02:45 ET | 4860 | 23.465 |
02:47 ET | 2600 | 23.44 |
02:49 ET | 9792 | 23.42 |
02:51 ET | 1531 | 23.43 |
02:54 ET | 2715 | 23.405 |
02:56 ET | 600 | 23.39 |
02:58 ET | 1321 | 23.42 |
03:00 ET | 1973 | 23.415 |
03:02 ET | 2388 | 23.4 |
03:03 ET | 1134 | 23.39 |
03:05 ET | 800 | 23.4 |
03:07 ET | 1000 | 23.395 |
03:09 ET | 5044 | 23.39 |
03:12 ET | 2300 | 23.4 |
03:14 ET | 2405 | 23.41 |
03:16 ET | 2465 | 23.395 |
03:18 ET | 1717 | 23.4 |
03:20 ET | 1387 | 23.395 |
03:21 ET | 4729 | 23.39 |
03:23 ET | 2962 | 23.385 |
03:25 ET | 5939 | 23.385 |
03:27 ET | 1600 | 23.38 |
03:30 ET | 2308 | 23.38 |
03:32 ET | 4412 | 23.355 |
03:34 ET | 3078 | 23.35 |
03:36 ET | 15957 | 23.33 |
03:38 ET | 1000 | 23.33 |
03:39 ET | 3032 | 23.345 |
03:41 ET | 10427 | 23.415 |
03:43 ET | 6358 | 23.46 |
03:45 ET | 8632 | 23.465 |
03:48 ET | 5141 | 23.465 |
03:50 ET | 10350 | 23.46 |
03:52 ET | 21857 | 23.455 |
03:54 ET | 21811 | 23.455 |
03:56 ET | 42712 | 23.38 |
03:57 ET | 55457 | 23.405 |
03:59 ET | 30578 | 23.4 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.0B | 6.7x | --- |
Exelixis Inc | 6.3B | 33.5x | -21.77% |
PTC Therapeutics Inc | 2.8B | -4.7x | --- |
Novavax Inc | 2.1B | -4.7x | --- |
P3 Health Partners Inc | 158.7M | -0.9x | --- |
Halozyme Therapeutics Inc | 5.6B | 18.3x | --- |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.0B |
---|---|
Revenue (TTM) | $1.7B |
Shares Outstanding | 169.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.45 |
EPS | $3.50 |
Book Value | $7.20 |
P/E Ratio | 6.7x |
Price/Sales (TTM) | 2.3 |
Price/Cash Flow (TTM) | 6.0x |
Operating Margin | 29.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.